About Jason C. Vigna

Jason Vigna defends public companies and their personnel against shareholder litigation. Representing clients in courts throughout the country and before the Securities and Exchange Commission, he makes securities class actions the focus of his practice. His concentration in the area has made him both effective and efficient, as demonstrated by his long list of early case dismissals.

Resolving federal and state securities disputes

Representing public companies of all sizes, Jason has particular experience advising life sciences, financial services and technology companies. In addition to representing them in general complex commercial litigation, he helps these businesses, as well as their directors and officers, resolve disputes involving federal and state shareholder- and fraud-related statutes, including the Securities Exchange Act of 1934, the Securities Act of 1933, the Racketeering Influenced and Corrupt Organizations (RICO) Act and the Delaware General Corporation Law.

Jason brings to his clients an understanding not only of securities law, but also of their businesses. His knowledge of pharmaceutical, financial services and other industries gives him a common language with his clients and greater insight into the legal strategies that will work for them. Among other successes, he has had numerous victories in litigation arising from Bernard Madoff's Ponzi scheme. He successfully defended an asset manager and its employees in more than 50 derivative, bankruptcy and individual actions arising from Madoff-related investments, as well as a global financial services company against multibillion-dollar RICO and bankruptcy clawback claims brought by the trustee of the Madoff estate.

Before entering private practice, Jason clerked for the Honorable J.P. Stadtmueller of the US District Court for the Eastern District of Wisconsin.

⇣   Expand to read more

Practice Focus

  • Securities litigation and enforcement
  • Class action and multidistrict litigation
  • Fiduciary litigation
  • Pharmaceutical and life sciences litigation
  • Financial services litigation

Representative Experience

  • Defended nationwide operator of physical therapy clinics against putative Section 10(b) securities class action alleging that company's accounting restatement resulted from knowing mischaracterization of non-controlling interests in its clinics held by clinics' managing therapists. US District Court for the Southern District of New York dismissed the allegations with prejudice, finding plaintiffs had alleged no facts from which fraudulent intent could be inferred.
  • Defended Angie's List, Inc. and its directors against consolidated lawsuits in the US District Court for the District of Indiana alleging defendants violated Section 14(a) of the Securities Exchange Act by supposedly omitting material information from proxy statement the company filed in connection with its merger with HomeAdvisor, Inc. Prior to shareholder vote on proposed merger, negotiated a limited disclosure-based settlement of all plaintiffs' allegations without the requirement of any discovery.
  • Defended pharmaceutical company and certain of its officers against putative securities class action lawsuit in the US District Court for the District of New Jersey. Plaintiff alleged defendants previously misrepresented likelihood that FDA would approve client's leading drug candidate for sale to public, causing its stock price to be artificially inflated, but dropped the suit.
  • Represented global defense technology firm in a multi-faceted dispute with former officers of largest operating subsidiary. Obtained pre-trial settlement.
  • Defended one of the world's leading financial service providers in trial and appeal involving allegations that the client committed fraud and breached a contract in connection with its sale of a subsidiary. Obtained dismissal of the most serious claims. *
  • Defended former CEO and former general counsel of largest broker on Chicago Mercantile Exchange against consolidated actions arising from company's collapse. Obtained complete pre-discovery dismissal. *
  • Represented special litigation committee of then-largest insurance and financial services company in the world in investigation of allegations that senior officers breached fiduciary duties to the company. *
  • Prepare underwriters of US-based telecommunications company's debt securities for trial involving allegations that underwriters defrauded purchasers of client's bonds.
  • Defended prominent international financial and travel-related services company against allegations that it illegally traded securities of a company on whose board one of its executives sat. Obtained complete pre-discovery dismissal and subsequent token settlement. *
* Experience prior to Katten

Publications

Presentations and Events

  • Participant
    July 18, 2019
  • 2019 Chubb Preferred Securities Panel Counsel Conference: Event-Driven Class Actions
    Presenter
    June 11, 2019
  • Spring 2019 BioNJ Legal, Compliance & Regulatory Forum - Life Sciences Securities Litigation: What Every Company Needs To Know
    Moderator
    April 25, 2019
  • Life Sciences Investment Conference: Current Trends in Securities Litigation Against Life Sciences and Venture Capital Companies
    Panelist
    November 9, 2017
  • 2016 Financial Services Symposium: The Securities Litigation Uniform Standards Act: A Still-Developing Tool for Defending Class and Mass Actions
    Presenter
    October 27, 2016
  • Clal Insurance 2016 Securities Litigation Seminar: Developments in Cyber Law and Potential Liability for Data Breaches
    Presenter
    July 12, 2016